UNSPSC 51263016: Urapidil fumarate

This classification denotes an adrenergic alpha-1 receptor antagonist and antihypertensive agent C20H29N5O3.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7565ZXN22A, chemically known as 6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1h,3h)-dione (2e)-but-2-enedioate (1:1), but more generally known as urapidil fumarate, which bears US NIH Compound Identifier 9870716. Most nations, for tariff and trade purposes, schedule urapidil fumarate under HS 29335995 and SITC 51576.

As of Q4 2014, URAPIDIL FUMARATE remains US FDA's Preferred Term for this commodity. SMILES: CN1C(CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3CCCCC3OC.C(=C/C(=O)O)\C(=O)O.

UNSPSC 51263016 Urapidil fumarate, a Commodity code, does not align with the recent state and local solicitation activity associated with it. The source shows no documented procurement of urapidil fumarate—a cardiovascular agent—under this code. Instead, the single recent opportunity linked to the code is Seminole County, Florida's IFB for naloxone and drug deactivation systems, which falls outside the code's stated pharmaceutical scope and represents a public health intervention product rather than a prescription antihypertensive agent.

Seminole County posted the opportunity (IFB60459723LAS) on June 30, 2026, with a response deadline of July 26, 2023, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. Vendors must include shipping and delivery costs in their bids, submit electronically through the county e-Procurement Portal, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace requirements. The contract term is two years with an optional one-year renewal and includes a three-month probationary period. The opportunity does not specify set-aside designations for disadvantaged enterprises. No additional state or local solicitations under this code appear in the source, indicating minimal or misaligned recent activity for urapidil fumarate procurement at the state and local level.